Laboratory Corporation of America Holdings (LH)

The analysis of Laboratory Corporation of America Holdings liquidity ratios reveals a mixed trend over the years.

1. Current Ratio:
- The current ratio, which measures the company's ability to cover its short-term obligations with its current assets, has generally shown a positive trend, increasing from 1.66 in 2020 to 1.92 in 2021. However, there was a slight decline in 2022 to 1.50, followed by a significant drop to 1.17 in 2023 before a slight recovery to 1.44 in 2024.
- While the current ratio remained above 1 in all years, indicating that the company has more current assets than current liabilities, the downward trend in recent years may raise concerns about the company's ability to meet its short-term obligations.

2. Quick Ratio:
- The quick ratio, which provides a more stringent measure of liquidity by excluding inventory from current assets, showed fluctuations over the years. The ratio increased from 1.26 in 2020 to 1.34 in 2021, but then decreased sharply to 0.86 in 2022. Subsequently, it further declined to 0.76 in 2023 before recovering to 1.04 in 2024.
- The decreasing quick ratio in 2022 and 2023 indicates that the company's ability to meet its short-term obligations without relying on inventory or other less liquid assets was challenged during those years.

3. Cash Ratio:
- The cash ratio, which focuses solely on the company's ability to cover its current liabilities with cash and cash equivalents, also exhibited fluctuations. The ratio increased from 0.45 in 2020 to 0.53 in 2021, but then dropped significantly to 0.14 in 2022. It improved slightly to 0.17 in 2023 and further increased to 0.46 in 2024.
- The lowest cash ratio in 2022 may indicate a potential liquidity strain if the company needed to rely heavily on cash to meet its immediate obligations during that period.

In conclusion, while Laboratory Corporation of America Holdings generally maintained ratios above critical levels, the declining trends in the quick ratio and cash ratio in certain years suggest the need for closer monitoring of liquidity management to ensure the company can meet its short-term obligations effectively.

---

Additional liquidity measure

The cash conversion cycle of Laboratory Corporation of America Holdings has shown a decreasing trend over the past five years. On December 31, 2020, the company's cash conversion cycle was 56.03 days, which decreased to 43.24 days by December 31, 2021. Subsequently, there was a slight increase to 50.96 days on December 31, 2022, followed by a decrease to 42.55 days on December 31, 2023, and further declined to 39.45 days by December 31, 2024.

This indicates that the company has been improving its efficiency in managing its cash flow and working capital, as a lower cash conversion cycle signifies that the company is able to convert its inventory and receivables into cash more quickly. Overall, the decreasing trend in the cash conversion cycle suggests that Laboratory Corporation of America Holdings has been effectively managing its liquidity and operations over the years.